Merck Sharp & Dohme Corp. v. Lupin Limited et al
| Merck Sharp & Dohme Corp. |
| Lupin Pharmaceuticals, Inc. and Lupin Limited |
| 1:2019cv00347 |
| February 19, 2019 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on March 12, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
SO ORDERED, re #11 MOTION for Pro Hac Vice Appearance of Attorney William R. Zimmerman, Jonathan E. Bachand and Andrea L. Cheek, filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. Signed by Judge Richard G. Andrews on 3/12/2019. (nms)
|
| Filing 11 MOTION for Pro Hac Vice Appearance of Attorney William R. Zimmerman, Jonathan E. Bachand and Andrea L. Cheek - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Ewing, Alexandra) |
| Pro Hac Vice Attorney Anthony H. Sheh for Merck Sharp & Dohme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-00310-RGA et al.(ceg) |
| Pro Hac Vice Attorney Anthony H. Sheh for Merck Sharp & Dohme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-00310-RGA et al.(ddp) |
| Pro Hac Vice Attorney Jingyuan Luo for Merck Sharp & Dohme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-00310-RGA et al.(ceg) |
| Filing 10 NOTICE of Appearance by Frederick L. Cottrell, III on behalf of Lupin Limited, Lupin Pharmaceuticals, Inc. (Cottrell, Frederick) |
| Filing 9 STIPULATION TO EXTEND TIME to move, answer or otherwise respond to the Complaint to April 22, 2019 - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Ewing, Alexandra) |
|
SO ORDERED, re #9 STIPULATION TO EXTEND TIME to move, answer or otherwise respond to the Complaint to April 22, 2019 (*Reset Answer Deadlines: Lupin Limited answer due 4/22/2019; Lupin Pharmaceuticals, Inc. answer due 4/22/2019). Signed by Judge Richard G. Andrews on 2/27/2019. (nms)
|
| Filing 8 SUMMONS Returned Executed by Merck Sharp & Dohme Corp.. Lupin Pharmaceuticals, Inc. served on 2/21/2019, answer due 3/14/2019. (Silver, Daniel) |
| Filing 7 DECLARATION of Mailing regarding service on Lupin Limited made on February 21, 2019, by Merck Sharp & Dohme Corp.. (Attachments: #1 Exhibits A-B)(Silver, Daniel) Modified on 2/25/2019 (nms). |
| CORRECTING ENTRY: The declaration at D.I. 7 and the summons at D.I. 8 have been removed from the docket per counsel's request as they contained errors. Counsel will refile. (nms) |
|
SO ORDERED, re (6 in 19-cv-321-RGA, 6 in 19-cv-318-RGA, 6 in 19-cv-312-RGA, 6 in 19-cv-314-RGA, 6 in 19-cv-310-RGA, 6 in 19-cv-316-RGA, 6 in 19-cv-313-RGA, 6 in 19-cv-320-RGA, 6 in 19-cv-347-RGA, 6 in 1:19-cv-00319-RGA, 6 in 19-cv-317-RGA, 6 in 19-cv-311-RGA, 6 in 19-cv-315-RGA) MOTION for Pro Hac Vice Appearance of Attorney Bruce R. Genderson, Jessamyn S. Berniker, Stanley E. Fisher, Shaun P. Mahaffy, Anthony H. Sheh, and Jinyuan Luo, filed by Merck Sharp & Dohme Corp.. Signed by Judge Richard G. Andrews on 2/22/2019. Associated Cases: 1:19-cv-00310-RGA et al.(nms)
|
| Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:19-cv-00310-UNA et al.(bkb) |
| Filing 6 MOTION for Pro Hac Vice Appearance of Attorney Bruce R. Genderson, Jessamyn S. Berniker, Stanley E. Fisher, Shaun P. Mahaffy, Anthony H. Sheh, and Jingyuan Luo - filed by Merck Sharp & Dohme Corp.. (Attachments: #1 Certifications)(Silver, Daniel) Modified on 2/22/2019 (nms). |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp. (lak) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (lak) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No earlier than 2/14/2019. Date of Expiration of Patent: 11/24/2026.Thirty Month Stay Deadline: No earlier than 8/14/2021. (lak) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lak) |
| Filing 1 COMPLAINT - filed against Lupin Limited, Lupin Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2573326.) - filed by Merck Sharp & Dohme Corp.. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(lak) |
| Summons Issued with Magistrate Consent Notice attached as to Lupin Limited on 2/19/2019; Lupin Pharmaceuticals, Inc. on 2/19/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (lak) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
